1
|
Jiang R, Kim SR, Christensen SR, Zubek A. Isolated single or pauci-nail lichen planus, three cases. JAAD Case Rep 2024; 46:52-56. [PMID: 38510835 PMCID: PMC10951446 DOI: 10.1016/j.jdcr.2024.01.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/22/2024] Open
Affiliation(s)
- Roy Jiang
- Department of Dermatology, Yale School of Medicine, New Haven, Connecticut
| | - Sa Rang Kim
- Department of Dermatology, Yale School of Medicine, New Haven, Connecticut
| | | | - Amanda Zubek
- Department of Dermatology, Yale School of Medicine, New Haven, Connecticut
| |
Collapse
|
2
|
Axler EN, Lipner SR. Nail lichen planus treatment safety. Expert Opin Drug Saf 2023; 22:1157-1168. [PMID: 38014463 DOI: 10.1080/14740338.2023.2288902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Accepted: 11/24/2023] [Indexed: 11/29/2023]
Abstract
AREAS COVERED Topical therapies for nail lichen planus (clobetasol propionate, topical tacrolimus, bath-PUVA), intralesional treatment (triamcinolone), and systemic treatment (corticosteroids, retinoids, small molecule inhibitors (jak/stat inhibitors)), TNF-alpha inhibitors (etanercept), systemic immunomodulators (oral calcineurin inhibitors, mycophenolate mophetil), and antimalarials (chloroquine), each with unique safety profiles and considerations. Herein, we discuss common and uncommon adverse events, as well as utilization for special populations, including pregnant and pediatric patients.
Collapse
Affiliation(s)
- Eden N Axler
- Albert Einstein College of Medicine, Bronx, New York, USA
| | - Shari R Lipner
- Weill Cornell Medicine, Department of Dermatology, New York, NY, USA
| |
Collapse
|
3
|
Grover C, Kharghoria G, Baran R. Nail lichen planus: A review of clinical presentation, diagnosis and therapy. Ann Dermatol Venereol 2022; 149:150-164. [PMID: 35272870 DOI: 10.1016/j.annder.2022.01.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2021] [Revised: 09/08/2021] [Accepted: 01/21/2022] [Indexed: 11/29/2022]
Abstract
Lichen planus is a multifaceted disease of complex etiopathogenesis. Nails are involved in up to 10% of patients with lichen planus. Although most cases are mild, serious consequences may occur due to rapid progression of the disease, the high risk of scarring, and the resulting irreversible damage to the nail structure. Permanent damage of at least one nail occurs in approximately 4-12% of patients with nail lichen planus. In this narrative review, we emphasize the pathophysiology of nail lichen planus, the emergent nature of the disease, and the spectrum of different clinical manifestations. Diagnosis of nail disease in general, and of nail lichen planus in particular, is rapidly evolving. This review provides a comprehensive account of the non-invasive and invasive diagnostic techniques and treatment options reported in the literature, with emphasis on the efficacy and safety of the drugs used, the associated evidence, and the factors to be taken into account in planning and providing adequate treatment. The role of aesthetic and camouflage options is also summarized.
Collapse
Affiliation(s)
- C Grover
- Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, 110091 Delhi, India.
| | - G Kharghoria
- Department of Dermatology and STD, All India Institute of Medical Sciences, 110029 Delhi, India
| | - R Baran
- Nail Disease Centre-42, Rue de Serbes, 06400 Cannes, France
| |
Collapse
|
4
|
Didona D, Pumnea T, von Braunmühl T, Wolf R. Effective use of alitretinoin in acitretin-refractory nail lichen planus. Int J Dermatol 2021; 61:e174-e176. [PMID: 34812508 DOI: 10.1111/ijd.15993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Revised: 07/16/2021] [Accepted: 11/06/2021] [Indexed: 11/30/2022]
Affiliation(s)
- Dario Didona
- Department of Dermatology and Allergology, Philipps-University, Marburg, Germany
| | - Teodora Pumnea
- Department of Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany
| | - Tanja von Braunmühl
- Department of Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany.,Dermatology and Allergology Clinic, Isarklinikum Munich, Munich, Germany
| | - Ronald Wolf
- Department of Dermatology and Allergology, Philipps-University, Marburg, Germany.,Department of Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany
| |
Collapse
|
5
|
Boch K, Langan EA, Kridin K, Zillikens D, Ludwig RJ, Bieber K. Lichen Planus. Front Med (Lausanne) 2021; 8:737813. [PMID: 34790675 PMCID: PMC8591129 DOI: 10.3389/fmed.2021.737813] [Citation(s) in RCA: 34] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2021] [Accepted: 10/11/2021] [Indexed: 12/17/2022] Open
Abstract
Lichen planus (LP) is a T cell-mediated disease affecting the stratified squamous epithelia of the skin and/or mucus membrane. Histologically, the disease is characterized by a lichenoid inflammatory infiltrate and vacuolar degeneration of the basal layer of the epidermis. LP has three major subtypes: Cutaneous, mucosal and appendageal LP. Rarely, it may affect the nails in the absence of skin and/or mucosal changes. LP may also be induced by several drugs, typically anti-hypertensive medication or be associated with infections, particularly viral hepatitis. The diagnosis is based on the clinical presentation and characteristic histological findings. Although the disease is often self-limiting, the intractable pruritus and painful mucosal erosions result in significant morbidity. The current first-line treatment are topical and/or systemic corticosteroids. In addition, immunosuppressants may be used as corticosteroid-sparing agents. These, however are often not sufficient to control disease. Janus kinase inhibitors and biologics (anti-IL-12/23, anti-IL17) have emerged as novel future treatment options. Thus, one may expect a dramatic change of the treatment landscape of LP in the near future.
Collapse
Affiliation(s)
- Katharina Boch
- Department of Dermatology, University of Lübeck, Lübeck, Germany
| | - Ewan A Langan
- Department of Dermatology, University of Lübeck, Lübeck, Germany.,Dermatological Sciences, University of Manchester, Manchester, United Kingdom
| | - Khalaf Kridin
- Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.,Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
| | - Detlef Zillikens
- Department of Dermatology, University of Lübeck, Lübeck, Germany
| | - Ralf J Ludwig
- Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany
| | - Katja Bieber
- Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany
| |
Collapse
|
6
|
Gupta MK, Lipner SR. Review of Nail Lichen Planus: Epidemiology, Pathogenesis, Diagnosis, and Treatment. Dermatol Clin 2021; 39:221-230. [PMID: 33745635 DOI: 10.1016/j.det.2020.12.002] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Nail lichen planus is an inflammatory disorder of the nails with potential for significant cosmetic disfigurement and functional impairment. Nail manifestations may be isolated or appear concurrently with other forms of lichen planus. Longitudinal ridging is the most common clinical finding, but progressive disease may result in irreversible scarring (dorsal pterygium) or permanent nail loss (anonychia). Data on treatment are limited to retrospective studies and case reports. The mainstays of treatment are intralesional and intramuscular corticosteroid injections and oral retinoids. There is a need for randomized controlled trials on nail lichen planus to more rigorously assess efficacy and outcomes.
Collapse
Affiliation(s)
- Mohit Kumar Gupta
- State University of New York Downstate College of Medicine, Brooklyn, NY, USA
| | - Shari R Lipner
- Department of Dermatology, Weill Cornell Medicine, 1305 York Avenue, New York, NY 10021, USA.
| |
Collapse
|
7
|
Alsenaid A, Alamri A, Ruzicka T, Wolf R. Effective and safe use of alitretinoin after acitretin failure in oral lichen planus. Dermatol Ther 2020; 33:e14441. [DOI: 10.1111/dth.14441] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2020] [Revised: 10/03/2020] [Accepted: 10/15/2020] [Indexed: 01/06/2023]
Affiliation(s)
- Adel Alsenaid
- Division of Dermatology, College of Medicine Shaqra University Dawadmi Saudi Arabia
- Department of Dermatology and Allergology Ludwig‐Maximilian University Munich Munich Germany
| | - Ali Alamri
- Department of Dermatology and Allergology Ludwig‐Maximilian University Munich Munich Germany
- Department of Dermatology Security Forces Hospital Riyadh Saudi Arabia
| | - Thomas Ruzicka
- Department of Dermatology and Allergology Ludwig‐Maximilian University Munich Munich Germany
| | - Ronald Wolf
- Department of Dermatology and Allergology Ludwig‐Maximilian University Munich Munich Germany
- Department of Dermatology and Allergology Philipps University Marburg Marburg Germany
| |
Collapse
|
8
|
Yesudian PD, de Berker DAR. Inflammatory nail conditions. Part 2: nail changes in lichen planus and alopecia areata. Clin Exp Dermatol 2020; 46:16-20. [PMID: 32799372 DOI: 10.1111/ced.14352] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2020] [Accepted: 05/29/2020] [Indexed: 02/03/2023]
Abstract
Nail changes are frequently seen in patients with cutaneous lichen planus and alopecia areata. This manuscript provides an updated overview on the clinical features, management and prognosis of both conditions. Searches of electronic databases PubMed and EMBASE were conducted and eligible articles were accessed. Practical management principles relevant to these two conditions are also included.
Collapse
Affiliation(s)
- P D Yesudian
- Department of Dermatology, Wrexham Maelor Hospital, Wrexham, UK
| | - D A R de Berker
- Department of Dermatology, Bristol Royal Infirmary, Bristol, UK
| |
Collapse
|
9
|
Ioannides D, Vakirlis E, Kemeny L, Marinovic B, Massone C, Murphy R, Nast A, Ronnevig J, Ruzicka T, Cooper S, Trüeb R, Pujol Vallverdú R, Wolf R, Neumann M. European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol 2020; 34:1403-1414. [DOI: 10.1111/jdv.16464] [Citation(s) in RCA: 42] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2019] [Accepted: 03/31/2020] [Indexed: 12/15/2022]
Affiliation(s)
- D. Ioannides
- Department of Dermatology and Venereology Aristotle University of Thessaloniki Medical School Thessaloniki Greece
| | - E. Vakirlis
- Department of Dermatology and Venereology Aristotle University of Thessaloniki Medical School Thessaloniki Greece
| | - L. Kemeny
- Department of Dermatology and Allergology University of Szeged Szeged Hungary
| | - B. Marinovic
- Department of Dermatology and Venereology University Hospital Center and School of Medicine Zagreb Zagreb Croatia
| | - C. Massone
- Department of Dermatology Medical University of Graz Graz Austria
| | - R. Murphy
- Department of Dermatology Nottingham University Hospital Nottingham UK
| | - A. Nast
- Department of Dermatology, Venereology and Allergy Division of Evidence‐Based Medicine Charité ‐ Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin Humboldt‐Universität zu Berlin and Berlin Institute of Health Berlin Germany
| | | | - T. Ruzicka
- Department of Dermatology and Allergology LMU Munich Germany
| | - S.M. Cooper
- Department of Dermatology Oxford University Hospitals NHS Trust and University of Oxford Oxford UK
| | - R.M. Trüeb
- Center for Dermatology and Hair Diseases Wallisellen Switzerland
| | | | - R. Wolf
- Department of Dermatology and Allergology LMU Munich Germany
| | - M. Neumann
- Department of Dermatology Erasmus MC Rotterdam The Netherlands
| |
Collapse
|
10
|
Iorizzo M, Tosti A, Starace M, Baran R, Daniel CR, Di Chiacchio N, Goettmann S, Grover C, Haneke E, Lipner SR, Rich P, Richert B, Rigopoulos D, Rubin AI, Zaiac M, Piraccini BM. Isolated nail lichen planus: An expert consensus on treatment of the classical form. J Am Acad Dermatol 2020; 83:1717-1723. [PMID: 32112995 DOI: 10.1016/j.jaad.2020.02.056] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2019] [Revised: 02/18/2020] [Accepted: 02/19/2020] [Indexed: 12/22/2022]
Abstract
Lichen planus is a benign inflammatory disorder of unknown etiology that may affect the skin, mucosae, scalp, and nails. When the nails are affected, it may lead to permanent destruction with severe functional and psychosocial consequences. Therefore, prompt diagnosis and early treatment are essential, even in mild cases. There are currently no guidelines for the management of nail lichen planus and the published literature on treatment is limited. The aim of this review is to provide practical management recommendations for the classical form of nail lichen planus, especially when restricted to the nails. Topical treatment has poor short-term efficacy and may cause long-term side effects. Instead, intralesional and intramuscular triamcinolone acetonide should be considered first-line therapies. Oral retinoids are second-line choices, and immunosuppressive agents may also be considered.
Collapse
Affiliation(s)
| | - Antonella Tosti
- University of Miami, Miller School of Medicine, Miami, Florida
| | - Michela Starace
- Department of Specialized, Experimental and Diagnostic Medicine, University of Bologna, Bologna, Italy
| | - Robert Baran
- University of Franche-Comté, Nail Disease Center, Cannes, France
| | - C Ralph Daniel
- University of Mississippi Medical Center, Jackson, Mississippi; University of Alabama, Birmingham, Alabama
| | - Nilton Di Chiacchio
- Department of Dermatology, Hospital do Servidor Público Municipal de São Paulo, São Paulo, Brazil
| | | | - Chander Grover
- Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, Delhi, India
| | - Eckart Haneke
- Department of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - Shari R Lipner
- Department of Dermatology, Weill Cornell Medicine, New York, New York
| | - Phoebe Rich
- Oregon Health and Science University, Portland, Oregon
| | - Bertrand Richert
- Saint Pierre - Brugmann and Queen Fabiola Children's University Hospitals, Université Libre de Bruxelles, Brussels, Belgium
| | - Dimitris Rigopoulos
- University Hospital of Venereal and Skin Diseases "A. Sygros," Athens, Athens, Greece
| | - Adam I Rubin
- Department of Dermatology, Hospital of the University of Pennsylvania, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
| | - Martin Zaiac
- Greater Miami Skin and Laser Center, Department of Dermatology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida
| | - Bianca Maria Piraccini
- Department of Specialized, Experimental and Diagnostic Medicine, University of Bologna, Bologna, Italy
| |
Collapse
|
11
|
Ricardo JW, Lipner SR. Recommendations for treatment of nail lichen planus during the COVID-19 pandemic. Dermatol Ther 2020; 33:e13551. [PMID: 32390258 PMCID: PMC7261978 DOI: 10.1111/dth.13551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2020] [Accepted: 05/06/2020] [Indexed: 02/07/2023]
Affiliation(s)
- Jose W. Ricardo
- Department of DermatologyWeill Cornell MedicineNYNew YorkUSA
| | - Shari R. Lipner
- Department of DermatologyWeill Cornell MedicineNYNew YorkUSA
| |
Collapse
|
12
|
Lee JY, Hong JS, Lee SH, Lee A. Successful treatment of frontal fibrosing alopecia with alitretinoin. Dermatol Ther 2019; 32:e13037. [DOI: 10.1111/dth.13037] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2018] [Revised: 07/24/2019] [Accepted: 07/25/2019] [Indexed: 12/19/2022]
Affiliation(s)
- Ji Young Lee
- Department of Dermatology, Dongguk University Ilsan Hospital, College of MedicineDongguk University Goyang Korea
| | - Jong Soo Hong
- Department of Dermatology, Dongguk University Ilsan Hospital, College of MedicineDongguk University Goyang Korea
| | - Seung Ho Lee
- Department of Dermatology, Dongguk University Ilsan Hospital, College of MedicineDongguk University Goyang Korea
| | - Ai‐Young Lee
- Department of Dermatology, Dongguk University Ilsan Hospital, College of MedicineDongguk University Goyang Korea
| |
Collapse
|
13
|
Husein‐ElAhmed H, Gieler U, Steinhoff M. Lichen planus: a comprehensive evidence‐based analysis of medical treatment. J Eur Acad Dermatol Venereol 2019; 33:1847-1862. [DOI: 10.1111/jdv.15771] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2018] [Accepted: 06/21/2019] [Indexed: 12/15/2022]
Affiliation(s)
- H. Husein‐ElAhmed
- Department of Dermatology and Venereology Hospital de Baza Granada Spain
- Translational Research Institute Academic Health System Medical School Hamad Medical Corporation Doha Qatar
| | - U. Gieler
- Translational Research Institute Academic Health System Medical School Hamad Medical Corporation Doha Qatar
- Department of Dermatology and Venereology Hamad Medical Corporation Doha Qatar
| | - M. Steinhoff
- Translational Research Institute Academic Health System Medical School Hamad Medical Corporation Doha Qatar
- Department of Dermatology and Venereology Hamad Medical Corporation Doha Qatar
- College of Medicine Weill Cornell Medicine‐Qatar Doha Qatar
- Medical School Qatar University Doha Qatar
- College of Medicine Weill Cornell University New York NY USA
| |
Collapse
|
14
|
Lee SY, Kim JW, Yu DS, Lee YB. Alitretinoin Treatment for Gefitinib-Induced Paronychia. Ann Dermatol 2019; 31:347-348. [PMID: 33911606 PMCID: PMC7992726 DOI: 10.5021/ad.2019.31.3.347] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2018] [Revised: 05/24/2018] [Accepted: 05/26/2018] [Indexed: 11/30/2022] Open
Affiliation(s)
- Soo Young Lee
- Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Jin-Wou Kim
- Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Dong Soo Yu
- Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Young Bok Lee
- Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| |
Collapse
|
15
|
Tziotzios C, Brier T, Lee JY, Saito R, Hsu CK, Bhargava K, Stefanato CM, Fenton DA, McGrath JA. Lichen planus and lichenoid dermatoses. J Am Acad Dermatol 2018; 79:807-818. [DOI: 10.1016/j.jaad.2018.02.013] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
16
|
Therapeutics for Adult Nail Psoriasis and Nail Lichen Planus: A Guide for Clinicians. Am J Clin Dermatol 2018; 19:559-584. [PMID: 29488102 DOI: 10.1007/s40257-018-0350-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Nail psoriasis (NP) and nail lichen planus (NLP) can be limiting, stigmatizing and difficult to treat. Dermatologists commonly treat psoriasis and lichen planus but when associated onychodystrophy is present or is an isolated finding, some develop apprehension. The goal of this review is to develop therapeutic ladders to be used as a guide for the management of NP and NLP in everyday clinical practice. Evidence-based therapies for NP are robust and range from topical treatments to conventional systemic therapies (i.e., methotrexate, cyclosporine), new oral agents (i.e., apremilast and tofacitinib), and biologics. The literature for treatment of NLP is severely limited, with therapy mainly consisting of topical, intralesional, or systemic corticosteroids or methotrexate.
Collapse
|
17
|
Shin K, Kim TW, Park SM, Lee HJ, Jin H, You HS, Shim WH, Kim GW, Kim HS, Ko HC, Kim BS, Kim MB. Alitretinoin can be a good treatment option for idiopathic recalcitrant trachyonychia in adults: an open-label study. J Eur Acad Dermatol Venereol 2018; 32:1810-1814. [DOI: 10.1111/jdv.15024] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2018] [Accepted: 04/06/2018] [Indexed: 10/17/2022]
Affiliation(s)
- K. Shin
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
| | - T.-W. Kim
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
| | - S.-M. Park
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
| | - H.-J. Lee
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
| | - H. Jin
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
| | - H.-S. You
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
| | - W.-H. Shim
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
| | - G.-W. Kim
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
- Biomedical Research Institute; Pusan National University Hospital; Busan Korea
| | - H.-S. Kim
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
- Biomedical Research Institute; Pusan National University Hospital; Busan Korea
| | - H.-C. Ko
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
| | - B.-S. Kim
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
- Biomedical Research Institute; Pusan National University Hospital; Busan Korea
| | - M.-B. Kim
- Department of Dermatology; School of Medicine; Pusan National University; Busan Korea
- Biomedical Research Institute; Pusan National University Hospital; Busan Korea
| |
Collapse
|
18
|
Lichen unguéal traité avec succès par acitrétine. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.03.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
19
|
Liu H, Li J, Yu L. Effects of acitretin on semen quality and reproductive hormone levels in patients with psoriasis vulgaris. DERMATOL SIN 2017. [DOI: 10.1016/j.dsi.2016.10.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
20
|
Khalil S, Bardawil T, Stephan C, Darwiche N, Abbas O, Kibbi AG, Nemer G, Kurban M. Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. J DERMATOL TREAT 2017; 28:684-696. [DOI: 10.1080/09546634.2017.1309349] [Citation(s) in RCA: 69] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- Samar Khalil
- Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
| | - Tara Bardawil
- Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
| | - Carla Stephan
- Department of Dermatology, American University of Beirut, Beirut, Lebanon
| | - Nadine Darwiche
- Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon
| | - Ossama Abbas
- Department of Dermatology, American University of Beirut, Beirut, Lebanon
| | - Abdul Ghani Kibbi
- Department of Dermatology, American University of Beirut, Beirut, Lebanon
| | - Georges Nemer
- Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon
| | - Mazen Kurban
- Department of Dermatology, American University of Beirut, Beirut, Lebanon
- Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon
- Department of Dermatology, Columbia University Medical Center, New York, NY, USA
| |
Collapse
|
21
|
|
22
|
Alamri A, Alsenaid A, Ruzicka T, Wolf R. Hypertrophic lichen planus - successful treatment with acitretin. Dermatol Ther 2016; 29:173-6. [DOI: 10.1111/dth.12337] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Ali Alamri
- Department of Dermatology and Allergology; Ludwig-Maximilian University Munich; Munich Germany
| | - Adel Alsenaid
- Department of Dermatology and Allergology; Ludwig-Maximilian University Munich; Munich Germany
| | - Thomas Ruzicka
- Department of Dermatology and Allergology; Ludwig-Maximilian University Munich; Munich Germany
| | - Ronald Wolf
- Department of Dermatology and Allergology; Ludwig-Maximilian University Munich; Munich Germany
| |
Collapse
|
23
|
Kolbach-Rengifo M, Navajas-Galimany L, Araneda-Castiglioni D, Reyes-Vivanco C. Efficacy of acitretin and topical clobetasol in trachyonychia involving all twenty nails. Indian J Dermatol Venereol Leprol 2016; 82:732-734. [DOI: 10.4103/0378-6323.190854] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
Alsenaid A, Alamri A, Prinz JC, Ruzicka T, Wolf R. Lichen planus of the lower limbs: successful treatment with psoralen cream plus ultraviolet A photochemotherapy. Dermatol Ther 2015; 29:109-13. [PMID: 26626735 DOI: 10.1111/dth.12321] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Lichen planus (LP) classifies into different subtypes depending on morphology and localization. Localized LP of the lower limb (LPLL) manifests a great challenge due to persistent itching, therapeutic resistance and the risk to develop into SCC. We report two cases with LPLL refractory to standard topical therapy, which were successfully treated with psoralen cream plus UVA photochemotherapy (cream-PUVA). We propose cream-PUVA as an alternative therapeutic option effective for localized LP of the lower limbs.
Collapse
Affiliation(s)
- Adel Alsenaid
- Department of Dermatology and Allergology, Munich, Germany
| | - Ali Alamri
- Department of Dermatology and Allergology, Munich, Germany
| | - Jörg C Prinz
- Department of Dermatology and Allergology, Munich, Germany
| | - Thomas Ruzicka
- Department of Dermatology and Allergology, Munich, Germany
| | - Ronald Wolf
- Department of Dermatology and Allergology, Munich, Germany
| |
Collapse
|
25
|
Abstract
Alitretinoin is a pan retinoic acid agonist. It was initially used as 0.1% gel in the management of localized Kaposi's sarcoma. At present, the use of systemic alitretinoin has proved extremely efficacious in the management of recalcitrant chronic hand eczema. Furthermore, there have been other retinoid responsive dermatosis that have demonstrated remission post usage of systemic alitretinoin. With a better toxicity profile, compared to the other systemic retinoids, alitretinoin could be considered a valuable treatment option in the near future for the treatment of these dermatologic disorders.
Collapse
Affiliation(s)
- Aditya Kumar Bubna
- Department of Dermatology, Sri Ramachandra University, Chennai, Tamil Nadu, India
| |
Collapse
|